Evidence map›Paper›PMID 31172225›Full record

ArticlePsychopharmacology2019

Dopamine D

Yuan-Yuan Liu, Tian-Xiao Wang, Ji-Chuan Zhou, Wei-Min Qu, Zhi-Li Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Large variability in the alkaloid content ofFrontiers in pharmacology · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Processing and Compatibility ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  19. Rapid Quality Identification of Decoction Pieces of Crude and ProcessedJournal of analytical methods in chemistry · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuan-Yuan Liu *Department of Pharmacology, School of Basic Medical Sciences; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Tian-Xiao Wang *Department of Pharmacology, School of Basic Medical Sciences; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Ji-Chuan ZhouDepartment of Pharmacology, School of Basic Medical Sciences; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, 200032, China.
Wei-Min QuDepartment of Pharmacology, School of Basic Medical Sciences; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, 200032, China. quweimin@fudan.edu.cn.
Zhi-Li HuangDepartment of Pharmacology, School of Basic Medical Sciences; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai, 200032, China. huangzl@fudan.edu.cn.ORCID http://orcid.org/0000-0001-9359-1150
Shanghai Medical College of Fudan University · CNFudan University · CN

Funding

National Basic Research Program of China 2015CB856401National Natural Science Foundation of China 31530035National Natural Science Foundation of China 31671099National Natural Science Foundation of China 31871072National Natural Science Foundation of China 81420108015Shanghai Committee of Science and Technology 17ZR1402000
6 · The paper itself

Abstract

rationaleLevo-tetrahydropalmatine (l-THP), an active ingredient of Corydalis yanhusuo, has been reported to be a partial agonist for dopamine D

objectivesTo investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition.

methodsA mouse model of chronic neuropathic pain induced by partial sciatic nerve ligation (PSNL) was employed. The antinociceptive and hypnotic effects of l-THP were evaluated by measurement of mechanical allodynia, thermal hyperalgesia, and electroencephalogram (EEG) recordings in PSNL mice. Pharmacological approaches and c-Fos expression were used to clarify the mechanisms of l-THP.

resultsIntraperitoneal injection of l-THP at 5 and 10 mg/kg not only significantly increased the mechanical threshold by 134.4% and 174.8%, and prolonged the thermal latency by 49.4% and 69.2%, but also increased non-rapid eye movement sleep by 17.5% and 29.6%, and decreased sleep fragmentation in PSNL mice, compared with the vehicle control. Moreover, the antinociceptive effect of l-THP was prevented by D

conclusionsThese findings indicated that l-THP exerted analgesic effects by agonism D

Indexed as

Analgesics, Non-NarcoticAnimalsBerberine AlkaloidsDisease Models, AnimalDopamine D2 Receptor AntagonistsElectroencephalographyHypnotics and SedativesMaleMiceMice, Inbred C57BLNeuralgiaReceptors, Dopamine D1Receptors, Dopamine D2Analgesics, Non-NarcoticBerberine AlkaloidsDopamine D2 Receptor AntagonistsHypnotics and SedativesReceptors, Dopamine D1Receptors, Dopamine D2tetrahydropalmatinec-FosDopamine receptorLevo-tetrahydropalmatineNeuropathic painSleep disturbance

Identifiers

PMID31172225
OpenAlexW2948896013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.